Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr
Arco Lab now holds a 50% stake in Neviton
Arco Lab now holds a 50% stake in Neviton
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The deal includes upfront payments, milestone payments and ongoing royalties
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The company received gross proceeds of approximately US$1.7 million and net proceeds,
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
AMI to become part of Enpro’s Sealing Technologies Segment
Subscribe To Our Newsletter & Stay Updated